Showing results (51-60 of 207) with videos related to
Sort By:
Pageof 21
Journal of Clinical Microbiology|August 1, 1996
Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR resultsK Kaul, S Luke, C McGurn, et al.Journal of Medical Virology|November 14, 2000
Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patientsA Lord, A S Bailey, P E Klapper, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogensSujata M Bhavnani, Jeffrey P Hammel, Alan Forrest, et al.Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.Antimicrobial Agents and Chemotherapy|June 9, 2016
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection ModelBrian VanScoy, Jennifer McCauley, Sujata M Bhavnani, et al.Antimicrobial Agents and Chemotherapy|December 27, 2005
Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variablesJeffrey P Hammel, Sujata M Bhavnani, Ronald N Jones, et al.The Journal of Antimicrobial Chemotherapy|August 15, 2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reductionPaul G Ambrose, Sujata M Bhavnani, Brenda B Cirincione, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureusP A Moise, A Forrest, S M Bhavnani, et al.Antimicrobial Agents and Chemotherapy|July 2, 2008
Association of fluconazole pharmacodynamics with mortality in patients with candidemiaJohn W Baddley, Mukesh Patel, Sujata M Bhavnani, et al.Pageof 21